Pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Phase 2 KEYNOTE-087 study Meeting Abstract


Authors: Chen, R. W.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N.; Ribrag, V.; Radford, J. A.; Tomita, A.; Shipp, M. A.; Wang, Y.; Ricart, A. D.; Balakumaran, A.; Moskowitz, C. H.
Abstract Title: Pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Phase 2 KEYNOTE-087 study
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 408s
Language: English
ACCESSION: WOS:000404711505068
DOI: 10.1200/JCO.2016.34.15_suppl.7555
PROVIDER: wos
Notes: Meeting Abstract: 7555 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Craig Moskowitz
    392 Moskowitz